Beacon Investment Advisory Services Inc. decreased its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 7.7% in the 4th quarter, Holdings Channel.com reports. The firm owned 11,759 shares of the company’s stock after selling 975 shares during the quarter. Beacon Investment Advisory Services Inc.’s holdings in Henry Schein were worth $814,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in HSIC. Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% during the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after buying an additional 170 shares in the last quarter. Versant Capital Management Inc increased its holdings in Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares in the last quarter. City State Bank acquired a new position in Henry Schein in the 4th quarter worth about $55,000. Farther Finance Advisors LLC raised its position in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after purchasing an additional 346 shares during the last quarter. Finally, Livforsakringsbolaget Skandia Omsesidigt boosted its stake in shares of Henry Schein by 282.1% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after purchasing an additional 1,100 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.
Henry Schein Stock Performance
HSIC stock opened at $74.75 on Friday. The firm has a market cap of $9.32 billion, a PE ratio of 30.76, a price-to-earnings-growth ratio of 2.03 and a beta of 0.89. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The stock has a 50-day moving average price of $72.70 and a 200-day moving average price of $70.86. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63.
Analyst Ratings Changes
Several research firms have recently issued reports on HSIC. Jefferies Financial Group upped their price objective on Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a research note on Thursday. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Barrington Research restated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a report on Wednesday, November 6th. Finally, Evercore ISI lifted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Seven research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $79.30.
Get Our Latest Stock Analysis on HSIC
Insider Activity
In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.14% of the stock is currently owned by company insiders.
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
See Also
- Five stocks we like better than Henry Schein
- How to Evaluate a Stock Before Buying
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Industrial Products Stocks Investing
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.